Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,877 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $534.78 | 6 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $237.78 | 2 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $145.32 | 2 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $138.18 | 1 | $0 (2021) |
| Silk Road Medical, Inc. | $135.26 | 1 | $0 (2023) |
| Paratek Pharmaceuticals, Inc. | $124.99 | 1 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $124.40 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $111.38 | 1 | $0 (2021) |
| Esperion Therapeutics, Inc. | $104.82 | 1 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $96.91 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $96.45 | 1 | Solventum Corporation ($96.45) |
| 2023 | $518.36 | 5 | ACADIA Pharmaceuticals Inc ($145.32) |
| 2022 | $322.82 | 4 | ABBVIE INC. ($197.83) |
| 2021 | $939.20 | 9 | AbbVie Inc. ($336.95) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/04/2024 | Solventum Corporation | ACTIV.A.C. (Device), PROMOGRAN PRISMA | Food and Beverage | Cash or cash equivalent | $96.45 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 09/12/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ANTIBIOTIC | ||||||
| 05/23/2023 | Silk Road Medical, Inc. | ENROUTE Transcarotid Stent (Device), ENROUTE Transcarotid Neuroprotection System | Food and Beverage | In-kind items and services | $135.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $112.79 | General |
| 03/22/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $72.66 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/22/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $72.66 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
| 05/19/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $76.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $95.51 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $89.38 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $138.18 | General |
| Category: NEUROLOGY | ||||||
| 08/20/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $96.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $125.75 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: Diabetes | ||||||
| 05/11/2021 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $104.82 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/09/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $124.40 | General |
| Category: PRIMARY CARE | ||||||
| 01/12/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $111.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 258 | 808 | $113,997 | $57,133 |
| 2022 | 4 | 217 | 575 | $80,759 | $34,603 |
| 2021 | 5 | 287 | 655 | $90,579 | $40,584 |
| 2020 | 6 | 245 | 358 | $79,518 | $26,094 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 146 | 666 | $91,193 | $45,073 | 49.4% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 65 | 76 | $13,300 | $7,265 | 54.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 28 | 45 | $6,165 | $3,089 | 50.1% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 19 | 21 | $3,339 | $1,706 | 51.1% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 114 | 434 | $59,418 | $24,895 | 41.9% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Office | 2022 | 46 | 55 | $9,625 | $4,782 | 49.7% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 28 | 54 | $7,398 | $3,130 | 42.3% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 17 | 18 | $2,862 | $1,226 | 42.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 12 | 14 | $1,456 | $569.79 | 39.1% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 118 | 414 | $56,718 | $24,941 | 44.0% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2021 | 33 | 38 | $6,650 | $3,400 | 51.1% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 24 | 56 | $7,672 | $3,378 | 44.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 33 | $4,950 | $2,261 | 45.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 33 | 44 | $4,576 | $2,009 | 43.9% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 23 | 23 | $4,025 | $1,969 | 48.9% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2021 | 19 | 20 | $3,180 | $1,392 | 43.8% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 20 | 27 | $2,808 | $1,233 | 43.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 85 | 164 | $33,526 | $11,438 | 34.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 39 | 40 | $15,960 | $5,421 | 34.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 44 | 76 | $10,799 | $3,712 | 34.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 41 | 42 | $10,344 | $3,016 | 29.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 11 | 11 | $4,389 | $1,289 | 29.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 25 | 25 | $4,500 | $1,218 | 27.1% |
About Sara Baker, FNP
Sara Baker, FNP is a Family healthcare provider based in Lewiston, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/24/2019. The National Provider Identifier (NPI) number assigned to this provider is 1700343936.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sara Baker, FNP has received a total of $1,877 in payments from pharmaceutical and medical device companies, with $96.45 received in 2024. These payments were reported across 19 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,877).
As a Medicare-enrolled provider, Baker has provided services to 1,007 Medicare beneficiaries, totaling 2,396 services with total Medicare billing of $158,414. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Lewiston, NY
- Active Since 02/24/2019
- Last Updated 02/24/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1700343936
Products in Payments
- UBRELVY (Drug) $534.78
- NUPLAZID (Drug) $145.32
- INGREZZA (Drug) $138.18
- ENROUTE Transcarotid Stent (Device) $135.26
- NUZYRA (Drug) $124.99
- OFEV (Drug) $124.99
- NURTEC ODT (Drug) $124.40
- FARXIGA (Drug) $111.38
- NEXLIZET (Drug) $104.82
- XARELTO (Drug) $96.91
- ACTIV.A.C. (Device) $96.45
- TRULICITY (Drug) $26.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lewiston
Ms. Elizabeth Printup, Fnp, FNP
Family — Payments: $9,160
Natalie Bubier, Fnp, FNP
Family — Payments: $3,178
Candice Hammerton, Np, NP
Family — Payments: $2,842
Theresa Smith, Fnp, FNP
Family — Payments: $2,495
Cody Harris, Cnp, CNP
Family — Payments: $1,428
Dr. Amanda Adams, Dnp, Fnp-Bc, DNP, FNP-BC
Family — Payments: $1,246